Intractable crying in infants and young children can be a language all of its own-capable of communicating underlying disease. Here's what pediatricians need to know to avoid getting lost in translation.
Dupilumab (Dupixent) becomes first FDA-approved drug for adolescent CRSwNP
September 13th 2024The landmark indication is supported by a couple of pivotal trials assessing dupilumab for patients with chronic rhinosinusitis with nasal polyps, as well as a pediatric severe asthma trial assessing the biologic.